Recently published data from Dr. Miron and a team of experts presents compelling evidence that may help you decide to incorporate EMD into your bone regeneration procedures.*
Gain insight, as they explain their rationale for the choice of methods and components and their findings, that could benefit your practice right away. You’ll get the answers to questions.
More predictable results, less invasive treatment and faster healing times** increase patient acceptance – the promise of EMD in treatment is very bright. Get the paper today and get the facts.
*Emdogain is approved for use in periodontal regeneration, including instrabony defects, Class II mandibular furcations with minimal interproximal bone loss, recession defects and in combination with allograft, autograft, bone derived xenograft, bioactive glass or beta-TCP in wide defects or where additional soft tissue support is needed.
**If tissue harvest and/or drawing of blood can be avoided